COVID-19 and comedications in atrial fibrillation-a case-control study in Stockholm.
Max BellAnders EkbomMarie LinderPublished in: European journal of epidemiology (2023)
To test the main hypothesis that anticoagulation reduces risk of hospitalization, intensive care unit (ICU) admission and death in COVID-19. Nested case-control study among patients with atrial fibrillation (AF) in Stockholm. COVID-19 cases were matched to five disease-free controls with same sex, born within ± 1 years. Source population was individuals in Stockholm with AF 1997-2020. Swedish regional and national registers are used. National registers cover hospitals and outpatient clinics, local registers cover primary care. Records were linked through the personal identity number assigned to each Swedish resident. Cases were individuals with COVID-19 (diagnosis, ICU admission, or death). The AF source population consisted of 179,381 individuals from which 7548 cases were identified together with 37,145 controls. The number of cases (controls) identified from hospitalization, ICU admission or death were 5916 (29,035), 160 (750) and 1472 (7,360). The proportion of women was 40% for hospitalization and death, but 20% and 30% for admission to ICU in wave one and two, respectively. Primary outcome was mortality, secondary outcome was hospitalization, tertiary outcome was ICU admission, all with COVID-19. Odds ratios (95% confidence interval) for antithrombotics were 0.79 (0.66-0.95) for the first wave and 0.80 (0.64-1.01) for the second wave. Use of anticoagulation among patients with arrythmias infected with COVID-19 is associated with lower risk of hospitalization and death. If further COVID-variants emerge, or other infections with prothrombotic properties, this emphasize need for physicians to ensure compliance among vulnerable patients.
Keyphrases
- coronavirus disease
- intensive care unit
- sars cov
- atrial fibrillation
- primary care
- emergency department
- mechanical ventilation
- respiratory syndrome coronavirus
- heart failure
- end stage renal disease
- quality improvement
- newly diagnosed
- chronic kidney disease
- gene expression
- metabolic syndrome
- acute coronary syndrome
- polycystic ovary syndrome
- cardiovascular events
- catheter ablation
- left ventricular
- type diabetes
- percutaneous coronary intervention
- coronary artery disease
- copy number
- left atrial appendage
- insulin resistance
- mitral valve
- patient reported outcomes